Report

  • Home |
  • Reports |
  • Global Next Generation Sequencing Market by Types (Sequencing by Synthesis, Ion Semiconductor Sequen....
src

Global Next Generation Sequencing Market by Types (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing) and by End-Users/Application (Diagnostics, Drug Discovery, Agriculture & Animal Research and Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2023 – 2032

 Report Code
 Category
 Published Date
 Pages
 Format
iSay-2259
Life Sciences
18 October 2023
215
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

Global Next Generation Sequencing Market:

iSay Research has published a new report titled Next Generation Sequencing Market Share, forecast data, In-Depth Analysis and Forecast, 2022. According to the report, Global Next Generation Sequencing Market in 2022 stood at USD 8.29 billion and is expected to reach USD 56.33 billion by 2032 growing at a CAGR of 21.12% from 2023 to 2032.

Next Generation Sequencing is the primary technology which is responsible for the increase in the field of oncology, complex disease testing, clinical diagnostics and Mendelian diseases. Next generation sequencing analyzes and minimizes the time that is required to identify the source of a condition as compared to sequential molecular tests, which contributes to improve the health outcome. Next generation sequencing provides detailed understanding of cancer screening programs which further quickens the therapy prescription procedures and benefit large proportion of the population. Next generation sequencing (NGS) is used and executed in various applications like agricultural & animal research, biomarker discovery, personalized medicine, oncology studies and others. Next generation sequencing (NGS) has efficient nucleotide analysis which replace conventional tools of genomics, especially microarray efficiently.

Next Generation Sequencing Market: Key Players

The research study includes profiles of leading companies operating in the global next generation sequencing market. Key players profiled in the report include: Thermo Fisher Scientific Inc., Hamilton Company, Illumina Inc., Oxford Nanopore Technologies, BGI Group, Agilent Technologies Inc., PerkinElmer Inc., QIAGEN, Lucigen and Macrogen.

Drivers for the Global Next Generation Sequencing Market:

Rise in the genome mapping programs is one of the major factor that is driving the growth of the global next generation sequencing market. Along with this, next generation sequencing have also developed an essential process of clinical diagnostics like oncology, Mendelian diseases, and complex disease testing which also drives the growth of the global next generation sequencing market. Moreover, the reduction of third-generation instruments with the introduction of palm-sized sequencers that has also driven the growth of the market.

Opportunities for the Global Next Generation Sequencing Market:

Rise in the opportunities in the cloud computing as a potential data management service in the next generation sequencing is one of the major factor that will drive the growth of the global next generation sequencing market in the forecast period. Along with this, Next Generation Sequencing (NGS) will witness diversification into a substantial number of clinical areas and will contribute to the improved health outcome are another factors that will enhance the growth of the global next generation sequencing market in the forecast period. Moreover, continuous evolution of next generation sequencing technologies with respect to efficiency and cost will boost the market in the future.

Restrains for the Global Next Generation Sequencing Market:

Rise in the regularization concerns over Next Generation Sequencing (NGS) based diagnostics is one of the major factor that is hampering the growth of the global next generation sequencing market. Along with this, ethical & legal limitations of NGS and lack of skilled professionals that are required for diagnostics and testing are some another factors that is also hampering the growth of the global next generation sequencing market.

Region Wise, Global Next Generation Sequencing Market Analysis:

On the basis of region, the AIOps market is segmented into North America, South America, Europe, Asia Pacific, and the Middle East and Africa. North America held the largest share in the market because of increasing applications of NGS in diagnostics and genomics research, the availability of research funding, and the development of NGS data analysis solutions. The European countries are also having the maximum share in the next generation sequencing market followed by the Asia Pacific region.

Covid-19: Impact and Recovery Analysis for Global Next Generation Sequencing Market:

The world is greatly affected by the uncertain raise of the covid-19 Pandemic among the population. The Corona virus outbreak has disrupted & disturbed every sector of business as well as human activity. In most parts of the world there has been a complete restriction set by governments regarding various activities and in turn this is greatly affecting the financial stability of industries like: Next Generation Sequencing market globally. Most of the industries and businesses like: Next Generation Sequencing are shifting to manufacturing equipment that can support the covid-19 spread from increasing and spreading. Biopharmaceutical innovators are working on the human response to the coronavirus pandemic to prepare a viable vaccine for the same. The biotech units are examining Covid-19 at an extraordinary rate and a substantial amount of funds are being put into the R&D, as well as the public and private sectors are expected to work in an agreement for the probable period, until a vaccine is developed for Covid-19.

Global Next Generation Sequencing Market: Product analysis
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
On the basis of type, sequencing by synthesis accounted for largest share of total revenue generated, because of the increasing demand for Illumina’s systems (major provider of NGS platforms) that is used by the SBS technology and the development of new and advanced NGS platforms.

Global Next Generation Sequencing Market: Application analysis
  • Diagnostics
  • Drug Discovery
  • Agriculture & Animal Research
  • Others
The demand of Global Next Generation Sequencing Market is highest from diagnostics, due to the increasing focus of key market players on developing NGS-based products & services, growing number of new cancer cases and favorable reimbursement scenario for NGS-based tests.

Global Next Generation Sequencing Market: Region analysis
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • U.K.
  • France
  • Germany
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Rest of L.A.
  • Middle East and Africa
  • Turkey
  • GCC
  • UAE
  • South Africa
  • Rest of Middle East
Snapshot:
 
Attributes Details
Market Size in 2023 USD 8.29 Billion
Market Forecast in 2032 USD 56.33 Billion
Compound Annual Growth Rate (CAGR) 21.12 %
Unit Revenue (USD Million) and Volume (Kilo Tons)
Segmentation By Type, By Application, By Region
By Type
  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing
By Application
  • Diagnostics
  • Drug Discovery
  • Agriculture & Animal Research
  • Others
By Region
  • North America: U.S and Canada
  • Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
  • APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Chile
  • The Middle East And Africa: South Africa, GCC, Rest of MEA
Base Year 2022
Historical Year 2018 - 2022
Forecast Year 2023 - 2032

Pivotal Fundamentals of the Global Next Generation Sequencing Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each next generation sequencing market player.
  • Region-wise and country-wise breakdown of the next generation sequencing market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global next generation sequencing market.
  • Year-on-year growth of the global next generation sequencing market in terms of value and volume.
Conclusion:

At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish next generation sequencing market and nurture business as it explains current global market as well as future market.
 

Chapter 1 Next Generation Sequencing Overview
            1.1 Product Overview and Scope of Next Generation Sequencing

Chapter 2 Impact of COVID 19
              2.1 Impact on Biotechnology Industry
              2.2 Impact on Next Generation Sequencing
              2.3 Consumer Buying Behavior based on Next Generation Sequencing
              2.4 Recovery and forecast Analysis based on Next Generation Sequencing

Chapter 3 Executive Summary  
            3.1 Drivers for Next Generation Sequencing: 
            3.2 Restrain for Next Generation Sequencing:
            3.3 Opportunity for Next Generation Sequencing: 
            3.4 Global Next Generation Sequencing, 2018 - 2032
            3.5 Global Next Generation Sequencing, by Region, 2018 - 2032
            3.6 Global Next Generation Sequencing, by Type, 2018 - 2032
            3.7 Global Next Generation Sequencing, by Application, 2018 - 2032

Chapter 4 Next Generation Sequencing Segment by Types (Product Category) 
            4.1 Global Next Generation Sequencing Revenue (USD Million) and Growth Rate (%) Comparison by Types (2018 - 2032) 
            4.2 Global Next Generation Sequencing Revenue Market Share (%) by Types in 2022
            4.3 Sequencing by Synthesis
            4.4 Ion Semiconductor Sequencing
            4.5 Single-molecule Real-time Sequencing
            4.6 Nanopore Sequencing

Chapter 5 Global Next Generation Sequencing Segment by Application 
            5.1 Global Next Generation Sequencing Revenue (USD Million) Comparison by Application (2018 - 2032) 
            5.2 Diagnostics
            5.3 Drug Discovery
            5.4 Agriculture & Animal Research
            5.5 Others

Chapter 6 Global Next Generation Sequencing by Regions (2018 - 2032) 
            6.1 Global Next Generation Sequencing Size and Growth Rate (%) Comparison by Regions (2018 - 2032) 
            6.2 North America Next Generation Sequencing Status and Prospect (2018 - 2032) 
            6.3 Europe Next Generation Sequencing Status and Prospect (2018 - 2032) 
            6.4 Asia Pacific Next Generation Sequencing Status and Prospect (2018 - 2032) 
            6.5 South America Next Generation Sequencing Status and Prospect (2018 - 2032) 
            6.6 Middle East & Africa Next Generation Sequencing Status and Prospect (2018 - 2032) 
            6.7 Global Next Generation Sequencing Size (2018 - 2032) 
                        6.7.1 Global Next Generation Sequencing Revenue Status and Outlook (2018 - 2032) 

Chapter 7 PESTEL Analysis
            7.1 Political Factors
            7.2 Economic Factors
            7.3 Social Factors
            7.4  Technological Factors
            7.5 Legal Factors
            7.6 Environment Factors

Chapter 8 Global Next Generation Sequencing Competition by Manufacturers
            8.1 Global Next Generation Sequencing Revenue and Share by Manufacturers (2018-2032) 

Chapter 9 Company (Top Players) Profiles and Key Data
            9.1 Thermo Fisher Scientific Inc.
                        9.1.1 Company Basic Information and Sales Area
                        9.1.2 Business Segment/ Overview
                        9.1.3 Investment in Research and Development
                        9.1.4 Next Generation Sequencing Product Types Specification
                        9.1.5 Key Developments
                        9.1.6 Business Strategy
            9.2 Hamilton Company
                        9.2.1  Company Basic Information and Sales Area
                        9.2.2 Business Segment/ Overview
                        9.2.3 Investment in Research and Development
                        9.2.4 Next Generation Sequencing Product Types Specification
                        9.2.5 Business Strategy
            9.3 Oxford Nanopore Technologies
                        9.3.1 Company Basic Information and Sales Area
                        9.3.2 Business Segment/ Overview
                        9.3.3 Next Generation Sequencing Product Types Specification
                        9.3.4 Key Developments
                        9.3.5 Business Strategy
            9.4 BGI Group
                        9.4.1 Company Basic Information and Sales Area. 
                        9.4.2 Business Segment/ Overview
                        9.4.3 Next Generation Sequencing Product Types Specification
                        9.4.4 Business Strategy
            9.5 Agilent Technologies Inc.
                        9.5.1 Company Basic Information and Sales Area. 
                        9.5.2 Business Segment/ Overview
                        9.5.3 Next Generation Sequencing Product Types Specification
                        9.5.4 Business Strategy
            9.6 PerkinElmer Inc.
                        9.6.1 Company Basic Information and Sales Area
                        9.6.2 Business Segment/ Overview
                        9.6.3 Next Generation Sequencing Product Types Specification
                        9.6.4 Business Strategy
            9.7 QIAGEN
                        9.7.1 Company Basic Information and Sales Area
                        9.7.2 Business Segment/ Overview
                        9.7.3 Investment in Research and Development
                        9.7.4 Next Generation Sequencing Product Types Specification
                        9.7.5 Key Developments
                        9.7.6 Business Strategy
            9.8 Lucigen
                        9.8.1 Company Basic Information and Sales Area. 
                        9.8.2 Business Segment/ Overview
                        9.8.3 Next Generation Sequencing Product Types Specification
                        9.8.4 Business Strategy
            9.9 Illumina Inc.
                        9.9.1 Company Basic Information and Sales Area
                        9.9.2 Business Segment/ Overview
                        9.9.3 Next Generation Sequencing Product Types Specification
                        9.9.4 Business Strategy
             9.10 Macrogen
                        9.10.1 Company Basic Information and Sales Area
                        9.10.2 Business Segment/ Overview
                        9.10.3 Next Generation Sequencing Product Types Specification
                        9.10.4 Business Strategy

Chapter 10 Global Next Generation Sequencing Revenue by Regions (2018 - 2032) 
            10.1 Global NEXT GENERATION SEQUENCING Revenue and Market Share (%) by Regions (2018 - 2032) 

Chapter 11 Global Next Generation Sequencing Revenue by Types
            11.1 Global NEXT GENERATION SEQUENCING Revenue and Market Share (%) by Types (2018 - 2032) 
Chapter 12 Global Next Generation Sequencing Analysis by Application
            12.1 Global NEXT GENERATION SEQUENCING Revenue (USD Million) and Market Share (%) by Application (2018 - 2032) 
            12.2 Global NEXT GENERATION SEQUENCING Revenue Growth Rate by Application (2018 - 2032) 
Chapter 13 North America NEXT GENERATION SEQUENCING Development Status and Outlook
            13.1 North America NEXT GENERATION SEQUENCING Size (2018 - 2032) 
                        13.1.1 North America NEXT GENERATION SEQUENCING Size by Type (USD Million) (2018 - 2032) 
            13.2 North America NEXT GENERATION SEQUENCING Size (2018 - 2032) 
                        13.2.1 North America NEXT GENERATION SEQUENCING Size by Application (USD Million) (2018 - 2032) 
             13.3 U.S
                         13.3.1 U.S. NEXT GENERATION SEQUENCING, by Type, 2018 - 2032
                         13.3.2 U.S. NEXT GENERATION SEQUENCING, by Application, 2018 - 2032
             13.4 Canada
                         13.4.1 Canada NEXT GENERATION SEQUENCING, by Type, 2018 - 2032
                         13.4.2 Canada NEXT GENERATION SEQUENCING, by Application, 2018 - 2032
             13.5 Mexico
                         13.5.1 Mexico NEXT GENERATION SEQUENCING, by Type, 2018 - 2032
                         13.5.2 Mexico NEXT GENERATION SEQUENCING, by Application, 2018 - 2032

Chapter 14 Europe Next Generation Sequencing Development Status and Outlook
            14.1 Europe Next Generation Sequencing Size (2018 - 2032) 
                        14.1.1 Europe Next Generation Sequencing Size by Type (USD Million) (2018 - 2032) 
            14.2 Europe Next Generation Sequencing Size (2018 - 2032) 
                        14.2.1 Europe Next Generation Sequencing Size by Application (USD Million) (2018 - 2032) 
             14.3 U.K.
                         14.3.1 U.K. Next Generation Sequencing, by Type, 2018 - 2032
                         14.3.2 U.K. Next Generation Sequencing, by Application, 2018 - 2032
             14.4 Germany
                         14.4.1 Germany Next Generation Sequencing, by Type, 2018 - 2032
                         14.4.2 Germany Next Generation Sequencing, by Application, 2018 - 2032
             14.5 France
                         14.5.1 France Next Generation Sequencing, by Type, 2018 - 2032
                         14.5.2 France Next Generation Sequencing, by Application, 2018 - 2032
             14.6 Italy
                         14.6.1 Italy Next Generation Sequencing, by Type, 2018 - 2032
                         14.6.2 Italy Next Generation Sequencing, by Application, 2018 - 2032
             14.7 Spain
                         14.7.1 Spain Next Generation Sequencing, by Type, 2018 - 2032
                         14.7.2 Spain Next Generation Sequencing, by Application, 2018 - 2032
             14.8 Rest of Europe
                         14.8.1 Rest of Europe Next Generation Sequencing, by Type, 2018 - 2032
                         14.8.2 Rest of Europe Next Generation Sequencing, by Application, 2018 - 2032

Chapter 15 Asia Pacific Next Generation Sequencing Development Status and Outlook
             15.1 Asia Pacific Next Generation Sequencing Size (2018 - 2032) 
                        15.1.1 Asia Pacific Next Generation Sequencing Size by Type (USD Million) (2018 - 2032) 
             15.2  Asia Pacific Next Generation Sequencing Size (2018 - 2032) 
                        15.2.1 Asia Pacific NEXT GENERATION SEQUENCING Size by Application (USD Million) (2018 - 2032) 
             15.3 China
                         15.3.1 China Next Generation Sequencing, by Type, 2018 - 2032
                         15.3.2 China Next Generation Sequencing, by Application, 2018 - 2032
             15.4 Japan
                         15.4.1 Japan Next Generation Sequencing, by Type, 2018 - 2032
                         15.4.2 Japan Next Generation Sequencing, by Application, 2018 - 2032
             15.5 India
                         15.5.1 India Next Generation Sequencing, by Type, 2018 - 2032
                         15.5.2 India Next Generation Sequencing, by Application, 2018 - 2032
             15.6 Southeast Asia
                         15.6.1 Southeast Asia Next Generation Sequencing, by Type, 2018 - 2032
                         15.6.2 Southeast Asia Next Generation Sequencing, by Application, 2018 - 2032

Chapter 16 South America Next Generation Sequencing Development Status and Outlook
            16.1 South America Next Generation Sequencing Size (2018 - 2032) 
                        16.1.1 South America Next Generation Sequencing Size by Type (USD Million) (2018 - 2032) 
            16.2 South America Next Generation Sequencing Size (2018 - 2032) 
                        16.2.1 South America Next Generation Sequencing Size by Application (USD Million) (2018 - 2032) 
             16.3 Brazil
                         16.3.1 Brazil Next Generation Sequencing, by Type, 2018 - 2032
                         16.3.2 Brazil Next Generation Sequencing, by Application, 2018 - 2032 
             16.4 Argentina
                         16.4.1 Argentina Next Generation Sequencing, by Type, 2018 - 2032
                         16.4.2 Argentina Next Generation Sequencing, by Application, 2018 - 2032 
             16.5 Colombia
                         16.5.1 Colombia Next Generation Sequencing, by Type, 2018 - 2032
                         16.5.2 Colombia Next Generation Sequencing, by Application, 2018 - 2032
             16.6 Rest of South America
                         16.6.1 Colombia Next Generation Sequencing, by Type, 2018 - 2032
                         16.6.2 Colombia Next Generation Sequencing, by Application, 2018 - 2032

Chapter 17 Middle East & Africa Next Generation Sequencing Development Status and Outlook
            17.1 Middle East & Africa Next Generation Sequencing Size (2018 - 2032) 
                        17.1.1 Middle East & Africa Next Generation Sequencing Size by Type (USD Million) (2018 - 2032) 
            17.2 Middle East & Africa Next Generation Sequencing Size (2018 - 2032) 
                        17.2.1 Middle East & Africa Next Generation Sequencing Size by Application (2018 - 2032) 
             17.3 UAE
                         17.3.1 UAE Next Generation Sequencing, by Type, 2018 - 2032
                         17.3.2 UAE Next Generation Sequencing, by Application, 2018 - 2032
             17.4 South Africa
                         17.4.1 South Africa Next Generation Sequencing, by Type, 2018 - 2032
                         17.4.2 South Africa Next Generation Sequencing, by Application, 2018 - 2032
             17.5 Egypt
                         17.5.1 Egypt Next Generation Sequencing, by Type, 2018 - 2032
                         17.5.2 Egypt Next Generation Sequencing, by Application, 2018 - 2032
             17.6 Rest of MEA
                         17.6.1 Rest of MEA Next Generation Sequencing, by Type, 2018 - 2032
                         17.6.2 Rest of MEA Next Generation Sequencing, by Application, 2018 - 2032

Chapter 18 Next Generation Sequencing Manufacturing Cost Analysis
            18.1 Proportion of Manufacturing Cost Structure
                        18.1.1 Raw Materials
                        18.1.2 Labor Cost
                        18.1.3 USA Labor Cost Analysis
                        18.1.4 EU Labor Costs Analysis
                        18.1.5 China Labor Costs Analysis
                        18.1.6 Manufacturing Expenses

Chapter 19 Marketing Strategy Analysis, Distributors/ Traders
            19.1 Marketing Channel
                        19.1.1 Direct Marketing
                        19.1.2 Indirect Marketing
                        19.1.3 Marketing Channel Development Trend
            19.2 Market Positioning
                        19.2.1 Pricing Strategy

Chapter 20 Global Next Generation Sequencing Forecast (2023 - 2032) 
            20.1 Global Next Generation Sequencing Revenue Forecast (2023 - 2032) 
                        20.1.1 Global Next Generation Sequencing Revenue (USD Million) and Growth Rate (%) Forecast (2023 - 2032) 
            20.2 Global Next Generation Sequencing Revenue (USD Million) Forecast by Regions (2023 - 2032) 
                        20.2.1 North America Next Generation Sequencing Revenue (USD Million) Forecast (2023 - 2032) 
                        20.2.2 Europe Next Generation Sequencing Revenue (USD Million) Forecast (2023 - 2032) 
                        20.2.3 Asia Pacific Next Generation Sequencing and Revenue (USD Million) Forecast (2023 - 2032) 
                        20.2.4 South America Next Generation Sequencing and Revenue (USD Million) Forecast (2023 - 2032) 
                        20.2.5 Middle East & Africa Next Generation Sequencing and Revenue (USD Million) Forecast (2023 - 2032) 
            20.3 Global Next Generation Sequencing Revenue Forecast by Type (2023 - 2032) 
            20.4 Global Next Generation Sequencing Revenue (USD Million) Forecast by Application (2023 - 2032) 

Chapter 21 North America Next Generation Sequencing Development Status and Outlook
            21.1 North America Next Generation Sequencing Size (2023 - 2032) 
                        21.1.1 North America Next Generation Sequencing Size by Type (USD Million) (2023 - 2032) 
            21.2 North America Next Generation Sequencing Size (2023 - 2032) 
                        21.2.1 North America Next Generation Sequencing Size by Application (USD Million) (2023 - 2032) 
             21.3 U.S.
                         21.3.1 U.S. Next Generation Sequencing, by Type, 2023 - 2032
                         21.3.2 U.S. Next Generation Sequencing, by Application, 2023 - 2032
             21.4 Canada
                         21.4.1 Canada Next Generation Sequencing, by Type, 2023 - 2032
                         21.4.2 Canada Next Generation Sequencing, by Application, 2023 - 2032
             21.5 Mexico
                         21.5.1 Mexico Next Generation Sequencing, by Type, 2023 - 2032
                         21.5.2 Mexico Next Generation Sequencing, by Application, 2023 - 2032

Chapter 22 Europe Next Generation Sequencing Development Status and Outlook
            22.1 Europe Next Generation Sequencing Size (2023 - 2032) 
                        22.1.1 Europe Next Generation Sequencing Size by Type (USD Million) (2023 - 2032) 
            22.2 Europe Next Generation Sequencing Size (2023 - 2032) 
                        22.2.1 Europe Next Generation Sequencing Size by Application (USD Million) (2023 - 2032) 
            22.3 U.K.
                         22.3.1 U.K. Next Generation Sequencing, by Type, 2023 - 2032
                         22.3.2 U.K. Next Generation Sequencing, by Application, 2023 - 2032
            22.4 Germany
                         22.4.1 Germany Next Generation Sequencing, by Type, 2023 - 2032
                         22.4.2 Germany Next Generation Sequencing, by Application, 2023 - 2032
            22.5 France
                         22.5.1 France Next Generation Sequencing, by Type, 2023 - 2032
                         22.5.2 France Next Generation Sequencing, by Application, 2023 - 2032
            22.6 Italy
                         22.6.1 France Next Generation Sequencing, by Type, 2023 - 2032
                         22.6.2 France Next Generation Sequencing, by Application, 2023 - 2032
            22.7 Spain
                         22.7.1 France Next Generation Sequencing, by Type, 2023 - 2032
                         22.7.2 France Next Generation Sequencing, by Application, 2023 - 2032
            22.8 Rest of Europe
                         22.8.1 France Next Generation Sequencing, by Type, 2023 - 2032
                         22.8.2 France Next Generation Sequencing, by Application, 2023 - 2032

Chapter 23 Asia Pacific Next Generation Sequencing Development Status and Outlook
            23.1 Asia Pacific Next Generation Sequencing Size (2023 - 2032) 
                        23.1.1 Asia Pacific Next Generation Sequencing Size by Type (USD Million) (2023 - 2032) 
            23.2 Asia Pacific Next Generation Sequencing Size (2023 - 2032) 
                        23.2.1 Asia Pacific Next Generation Sequencing Size by Application (USD Million) (2023 - 2032) 
            23.3 China
                         23.3.1 China Next Generation Sequencing, by Type, 2023 - 2032
                         23.3.2 China Next Generation Sequencing, by Application, 2023 - 2032
            23.4 Japan
                         23.4.1 Japan Next Generation Sequencing, by Type, 2023 - 2032
                         23.4.2 Japan Next Generation Sequencing, by Application, 2023 - 2032
            23.5 India
                         23.5.1 India Next Generation Sequencing, by Type, 2023 - 2032
                         23.5.2 India Next Generation Sequencing, by Application, 2023 - 2032
            23.6 Southeast Asia
                         23.6.1 Southeast Asia Next Generation Sequencing, by Type, 2023 - 2032
                         23.6.2 Southeast Asia Next Generation Sequencing, by Application, 2023 - 2032

Chapter 24 South America Next Generation Sequencing Development Status and Outlook
            24.1 South America Next Generation Sequencing Size (2023 - 2032) 
                        24.1.1 South America Next Generation Sequencing Size by Type (USD Million) (2023 - 2032) 
            24.2 South America Next Generation Sequencing Size (2023 - 2032) 
                        24.2.1 South America Next Generation Sequencing Size by Application (USD Million) (2023 - 2032) 
             24.3 Brazil
                         24.3.1 Brazil Next Generation Sequencing, by Type, 2023 - 2032
                         24.3.2 Brazil Next Generation Sequencing, by Application, 2023 - 2032 
             24.4 Argentina
                         24.4.1 Argentina Next Generation Sequencing, by Type, 2023 - 2032
                         24.4.2 Argentina Next Generation Sequencing, by Application, 2023 - 2032 
             24.5 Colombia
                         24.5.1 Colombia Next Generation Sequencing, by Type, 2023 - 2032
                         24.5.2 Colombia Next Generation Sequencing, by Application, 2023 - 2032
             24.6 Rest of South America
                         24.6.1 Colombia Next Generation Sequencing, by Type, 2023 - 2032
                         24.6.2 Colombia Next Generation Sequencing, by Application, 2023 - 2032

Chapter 25 Middle East & Africa Next Generation Sequencing Development Status and Outlook
            25.1 Middle East & Africa Next Generation Sequencing Size (2023 - 2032) 
                        25.1.1 Middle East & Africa Next Generation Sequencing Size by Type (USD Million) (2023 - 2032) 
            25.2 Middle East & Africa Next Generation Sequencing Size (2023 - 2032) 
                        25.2.1 Middle East & Africa Next Generation Sequencing Size by Application (USD Million) (2023 - 2032) 
             25.3 UAE
                         25.3.1 UAE Next Generation Sequencing, by Type, 2023 - 2032
                         25.3.2 UAE Next Generation Sequencing, by Application, 2023 - 2032
             25.4 South Africa
                         25.4.1 South Africa Next Generation Sequencing, by Type, 2023 - 2032
                         25.4.2 South Africa Next Generation Sequencing, by Application, 2023 - 2032
             25.5 Egypt
                         25.5.1 Egypt Next Generation Sequencing, by Type, 2023 - 2032
                         25.5.2 Egypt Next Generation Sequencing, by Application, 2023 - 2032
             25.6 Rest of MEA
                         25.6.1 Rest of MEA Next Generation Sequencing, by Type, 2023 - 2032
                         25.6.2 Rest of MEA Next Generation Sequencing, by Application, 2023 - 2032

Chapter 26 Research Findings and Conclusion

No Methodology

No Available

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase